Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C14H23N3S2.C6H8O7 |
| Molecular Weight | 489.606 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)CC(O)(CC(O)=O)C(O)=O.CCCCCCSC1=NSN=C1C2=CCCN(C)C2
InChI
InChIKey=WIOWZFAHNWMORW-UHFFFAOYSA-N
InChI=1S/C14H23N3S2.C6H8O7/c1-3-4-5-6-10-18-14-13(15-19-16-14)12-8-7-9-17(2)11-12;7-3(8)1-6(13,5(11)12)2-4(9)10/h8H,3-7,9-11H2,1-2H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)
Tazomeline (also known as LY 287041), a neuropsychiatric agent, is a muscarinic M1 acetylcholine receptor agonist that was studied in patients with cognitive dysfunction. Tazomeline participated in clinical trials for the treatment of Alzheimer’s disease and dementia. However, all these studied were discontinued for unknown reasons.
Originator
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C47796
Created by
admin on Fri Dec 15 16:32:37 GMT 2023 , Edited by admin on Fri Dec 15 16:32:37 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C66581
Created by
admin on Fri Dec 15 16:32:37 GMT 2023 , Edited by admin on Fri Dec 15 16:32:37 GMT 2023
|
PRIMARY | |||
|
175615-45-9
Created by
admin on Fri Dec 15 16:32:37 GMT 2023 , Edited by admin on Fri Dec 15 16:32:37 GMT 2023
|
PRIMARY | |||
|
23209321
Created by
admin on Fri Dec 15 16:32:37 GMT 2023 , Edited by admin on Fri Dec 15 16:32:37 GMT 2023
|
PRIMARY | |||
|
O494QX2F4D
Created by
admin on Fri Dec 15 16:32:37 GMT 2023 , Edited by admin on Fri Dec 15 16:32:37 GMT 2023
|
PRIMARY | |||
|
CHEMBL131819
Created by
admin on Fri Dec 15 16:32:37 GMT 2023 , Edited by admin on Fri Dec 15 16:32:37 GMT 2023
|
PRIMARY | |||
|
DTXSID10938688
Created by
admin on Fri Dec 15 16:32:37 GMT 2023 , Edited by admin on Fri Dec 15 16:32:37 GMT 2023
|
PRIMARY | |||
|
HH-88
Created by
admin on Fri Dec 15 16:32:37 GMT 2023 , Edited by admin on Fri Dec 15 16:32:37 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
PARENT (SALT/SOLVATE)
SUBSTANCE RECORD
